GDIT given prime position on $10 billion medical research contract

General Dynamics Information Technology (GDIT), a business unit of General Dynamics, has been awarded the Omnibus IV Medical Research and Development Contract by the Defense Health Agency (DHA). The indefinite delivery/indefinite quantity contract (IDIQ) has a total ceiling of $10 billion with a five-year base period and one five-year option.

The award grants GDIT the opportunity to compete for task orders in four market segments encompassing program areas including medical simulation technologies; infectious diseases; military health, performance and recovery; clinical and rehabilitative medicine; and emerging science and technology, according to a press release.

“GDIT has partnered with the Military Health System for more than 30 years. We are honored to support our nation’s service members and their families with advanced medical research and technical expertise that will enhance their health and safety,” said Kamal Narang, GDIT vice president and general manager for Federal Health, in a statement.

The company works with military health partners, such as the Military Health System, to contribute to research in areas such as traumatic brain injuries and infectious diseases.

The DHA helps the U.S. Army, Navy and Air Force medical services provide a “medically ready force to combatant commands in peacetime and wartime,” the press release said.

General Dynamics is a global aerospace and defense company with GDIT having operations in Coralville. In July, the company announced its supercomputers would begin running National Oceanic and Atmospheric Administration (NOAA) forecast models.

The U.S. Government Accountability Office (GAO) denied a protest from GDIT over an $11.5 billion defense contract won by Leidos Inc in June. GDIT felt their proposal was overlooked but the GAO ultimately sided with the Defense Information Systems Agency, according to Virginia Business.